Mitchell Sinkler & Starr Zoetis Inc. Transaction History
Mitchell Sinkler & Starr
- $387 Million
- Q2 2024
A detailed history of Mitchell Sinkler & Starr transactions in Zoetis Inc. stock. As of the latest transaction made, Mitchell Sinkler & Starr holds 3,091 shares of ZTS stock, worth $587,197. This represents 0.14% of its overall portfolio holdings.
Number of Shares
3,091
Previous 2,462
25.55%
Holding current value
$587,197
Previous $416,000
28.61%
% of portfolio
0.14%
Previous 0.1%
Shares
5 transactions
Others Institutions Holding ZTS
# of Institutions
1,897Shares Held
423MCall Options Held
1.15MPut Options Held
1.2M-
Vanguard Group Inc Valley Forge, PA41.2MShares$7.83 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$7 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.7MShares$3.74 Billion0.15% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16.2MShares$3.07 Billion2.53% of portfolio
-
Bank Of America Corp Charlotte, NC15.1MShares$2.87 Billion0.23% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $88.9B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...